DrugEBIlity statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Structure-based virtual screening chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

DrugEBIlity specifications


Unique identifier OMICS_19740
Name DrugEBIlity
Software type Application/Script
Interface Web user interface
Restrictions to use None
License Creative Commons - Attribution Share-Alike 3.0 Unported license
Computer skills Basic
Stability Stable
Maintained Yes

Additional information


DrugEBIlity in publications

PMCID: 5688804
PMID: 29115931
DOI: 10.1186/s12885-017-3726-2

[…] 42 of which presented structure-based druggability (fig. ), as they showed potential small molecule binding pockets in an analysis based on the chembl strudel https://www.ebi.ac.uk/chembl/drugebility/) (drugebility) methodology. among these genes, 10 exhibited ligand-based druggability scores falling within the 75% percentile or above defined for all of the proteins in the platform […]

PMCID: 3441041
PMID: 22788793
DOI: 10.1021/jm300346w

[…] that may not be representative of the family as a whole., many structure-based druggability prediction methods have been published in recent years, these include dlid, dogsitescorer, the ebi’s drugebility, drugpred, fpocket, mappod, screen, and sitemap. reviews by hajduk et al. and fauman et al. cover a number of these methods and some of the challenges in computational druggability […]

To access a full list of publications, you will need to upgrade to our premium service.

DrugEBIlity reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review DrugEBIlity